Temasek Holdings (Private) LTD Verve Therapeutics, Inc. Transaction History

Temasek Holdings (Private) LTD

  • $24.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 15, 2023
BUY
$15.63 - $41.49 $429,137 - $1.14 Million
27,456 New
27,456 $943,000
Q3 2022

Apr 05, 2023
BUY
$15.63 - $41.49 $429,137 - $1.14 Million
27,456 New
27,456 $943,000
Q3 2022

Nov 14, 2022
BUY
$15.63 - $41.49 $429,137 - $1.14 Million
27,456 New
27,456 $943,000

Others Institutions Holding VERV

# of Institutions
186
Shares Held
73.3M
Call Options Held
85K
Put Options Held
215K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $317M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email